---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042292"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:47:39.528236+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Anebulo stockholders approve increase in authorized shares and re-elect directors

## Summary
- Stockholders re-elected Jason M. Aryeh and Bimal Shah as Class III directors with ~23.1M votes for each.
- Ratified EisnerAmper LLP as independent auditor for fiscal 2024 (23,302,065 for, 2,075 against).
- Approved amendment to increase authorized common shares from 40M to 50M (23,263,127 for).
- The authorized share amendment was filed with Delaware Secretary of State on Nov 20, 2023.

## SEC filing metadata
- accession: 0001493152-23-042292
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042292
- JSON: https://secwatch.observer/filing/0001493152-23-042292.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042292.txt

## Key facts
- Shareholder Votes
  Anebulo Pharmaceuticals, Inc. shareholders approved Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000. at the 2023-11-20 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-11-20
  source text: Proposal No. 3 – Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm
- Shareholder Votes
  Anebulo Pharmaceuticals, Inc. shareholders approved Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024. at the 2023-11-20 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-11-20
  source text: Proposal No. 2 – Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm
- Shareholder Votes
  Anebulo Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-11-20 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-11-20
  source text: Proposal No. 1 - Election of Directors The stockholders elected the following two individuals to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders as Class III directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.